Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $33.6500 (6.96%) ($29.5400 - $33.8800) on Wed. Feb. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.64% (three month average) | RSI | 84 | Latest Price | $33.6500(6.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 6.6% a day on average for past five trading days. | Weekly Trend | IOVA advances 10.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(44%) ARKK(43%) | Factors Impacting IOVA price | IOVA will decline at least -2.32% in a week (0% probabilities). VIXM(-28%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.32% (StdDev 4.64%) | Hourly BBV | 0 () | Intraday Trend | 8.4% | | | |
|
5 Day Moving Average | $28.13(19.62%) | 10 Day Moving Average | $26.25(28.19%) | 20 Day Moving Average | $24.66(36.46%) | To recent high | 0% | To recent low | 55.5% | Market Cap | $4.928b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |